Pharmaceutical CAS 140462-76-6 Olopatadine HCl Purity 99% Olopatadine Hydrochloride Tablet Powder Olopatadine

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Dsung-Olopatadine
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Olopatadine
• Name: Olopatadine Powder
• Appearance: White or off-White Solid Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediate
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 113806-05-6
• Mf: C21h23no3
• MW: 337.41
• Density: 1.221 g/cm3
• Melting Point: 188-189.5 C
• Boiling Point: 523 Cat760mmhg
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 4 Ton/Month

Product Description

Pharmaceutical CAS 140462-76-6 Olopatadine Hcl Purity 99% Olopatadine Hydrochloride Tablet Powder Olopatadine

 

Product Description

Product Details

Product Name	Olopatadine
CAS No.	113806-05-6
MF	C21H23NO3
MW	337.41
Appearance and shape	White or off-white solid powder

Olopatadine hydrochloride is an ophthalmic antihistamine that inhibits release of histamine from mast cells and is a relatively selective histamine H1 antagonist.  It inhibits type 1 immediate hypersensitivity reactions.  Olopatadine hydrochloride is indicated in the temporary relief of itching caused by allergic conjunctivitis.  H1 antagonists have an established and valued place in the symptomatic treatment of various immediate hypersensitivity reactions.  In addition, the central properties of some of the series are of therapeutic value for suppressing motion sickness or for sedation.

Application & Function

Olopatadine hydrochloride is an anti-allergic drug. It has the dual effects of inhibiting the release of histamine and selectively antagonizing HI receptors, and has no central nervous system inhibition and cardiac toxic side effects that are common with HI receptor antagonist antiallergic drugs. The drug can not only inhibit the release of histamine from mast cells, but also antagonize H1 receptors more selectively, and has no effect on α adrenergic receptors, dopamine receptors, and M1 and M2 receptors. Among them, the side effects of the central nervous system are few. , Is a new generation of antiallergic drugs of choice.

Specification